Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bone Marrow Transplantation|June 28, 2016
Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioningS H Shin, Y W Jeon, J H Yoon, et al.
Bone Marrow Transplantation|November 7, 2012
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failureS-H Shin, S-A Yahng, J-H Yoon, et al.
Leukemia|June 19, 2012
Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemiaS Lee, D-W Kim, B-S Cho, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 25, 2012
Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimensS-H Kim, S Y Kee, D-G Lee, et al.
Bone Marrow Transplantation|July 30, 2013
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?J-H Yoon, W-S Min, H-Je Kim, et al.
Bone Marrow Transplantation|September 25, 2012
Risk and prognostic factors for acute GVHD based on NIH consensus criteriaS-E Lee, B-S Cho, J-H Kim, et al.
Bone Marrow Transplantation|November 29, 2016
Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndromeS-A Yahng, Y-W Jeon, J-H Yoon, et al.
Bone Marrow Transplantation|December 16, 2014
Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALLM Kim, J Park, D-W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patientsS J Seong, M Lim, S K Sohn, et al.
Pageof 5